LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Momelotinib | 0.04 | uM | LJP5 | 2 | P12 | 72 | hr | 1401 | 4190 | 4213 | 0.9945 | 0.9930 |
| SK-BR-3 | Momelotinib | 0.04 | uM | LJP5 | 3 | P12 | 72 | hr | 1401 | 4415 | 4545 | 0.9712 | 0.9659 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 1401 | 3926 | 3978 | 0.9868 | 0.9824 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 1401 | 4056 | 4213 | 0.9627 | 0.9527 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 1401 | 4451 | 4545 | 0.9791 | 0.9753 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 1 | P10 | 72 | hr | 1401 | 3786 | 3978 | 0.9516 | 0.9352 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 2 | P10 | 72 | hr | 1401 | 3904 | 4213 | 0.9266 | 0.9062 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 3 | P10 | 72 | hr | 1401 | 4150 | 4545 | 0.9129 | 0.8955 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 1 | P09 | 72 | hr | 1401 | 3373 | 3978 | 0.8478 | 0.7922 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 2 | P09 | 72 | hr | 1401 | 3503 | 4213 | 0.8314 | 0.7805 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 3 | P09 | 72 | hr | 1401 | 3706 | 4545 | 0.8152 | 0.7733 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 1 | P08 | 72 | hr | 1401 | 2574 | 3978 | 0.6470 | 0.4976 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 2 | P08 | 72 | hr | 1401 | 3044 | 4213 | 0.7225 | 0.6298 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 3 | P08 | 72 | hr | 1401 | 3035 | 4545 | 0.6676 | 0.5764 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 1 | P07 | 72 | hr | 1401 | 1496 | 3978 | 0.3760 | 0.0443 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 2 | P07 | 72 | hr | 1401 | 1697 | 4213 | 0.4028 | 0.1280 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 3 | P07 | 72 | hr | 1401 | 1705 | 4545 | 0.3751 | 0.1224 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 1 | L06 | 72 | hr | 1401 | 4335 | 3978 | 1.0896 | 1.1173 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 2 | L06 | 72 | hr | 1401 | 4604 | 4213 | 1.0927 | 1.1149 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 3 | L06 | 72 | hr | 1401 | 4516 | 4545 | 0.9934 | 0.9922 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 1401 | 3963 | 3978 | 0.9961 | 0.9948 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 1401 | 4191 | 4213 | 0.9947 | 0.9933 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 1401 | 4525 | 4545 | 0.9954 | 0.9946 |
| SK-BR-3 | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 1401 | 3601 | 3978 | 0.9051 | 0.8718 |
| SK-BR-3 | Fedratinib | 0.37 | uM | LJP5 | 2 | L04 | 72 | hr | 1401 | 3982 | 4213 | 0.9451 | 0.9301 |